(Q72068004)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

title

Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference

B J Dezube

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

M L Sherman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

J L Fridovich-Keil

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

J Allen-Ryan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

A B Pardee

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

publication date

1 January 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

57-60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01789132

23 October 2019

exact match

0 references

cites work

Cachectin: more than a tumor necrosis factor

1 reference

12 December 2020

Pentoxifylline prevents tumor necrosis factor-induced lung injury

1 reference

12 December 2020

Oxpentifylline in endotoxaemia.

1 reference

12 December 2020

Tumors secreting human TNF/cachectin induce cachexia in mice

1 reference

12 December 2020

Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients

1 reference

12 December 2020

Cytokine dysregulation in AIDS: in vivo overexpression of mRNA of tumor necrosis factor-alpha and its correlation with that of the inflammatory cytokine GRO

1 reference

12 December 2020

Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence

1 reference

12 December 2020

Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo

1 reference

12 December 2020

Pentoxifylline and wellbeing in patients with cancer

1 reference

12 December 2020

EVIDENCE FOR TUMOUR NECROSIS FACTOR/CACHECTIN PRODUCTION IN CANCER

1 reference

12 December 2020

Pentoxifylline (Trental) decreases the replication of the human immunodeficiency virus type 1 in human peripheral blood mononuclear cells and in cultured T cells

1 reference

12 December 2020

Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor

1 reference

12 December 2020

Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression

1 reference

12 December 2020

Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat

1 reference

12 December 2020

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

1 reference

12 December 2020

Recombinant human tumor necrosis factor administered as a five-day continuous infusion in cancer patients: phase I toxicity and effects on lipid metabolism

1 reference

12 December 2020

Molecular cloning of the complementary DNA for human tumor necrosis factor.

1 reference

12 December 2020

Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy

1 reference

12 December 2020

Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans

1 reference

12 December 2020

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline

1 reference

12 December 2020

Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality.

1 reference

12 December 2020

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

1 reference

12 December 2020

Number and evolutionary conservation of alpha- and beta-tubulin and cytoplasmic beta- and gamma-actin genes using specific cloned cDNA probes

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01789132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7678547%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference